With the recent launch announcement of the phase 3 trial for Paltusotine – Crinetics new nonpeptide oral drug candidate for acromegaly – we asked Dr. Alessandra Casagrande, their new Medical Science Director, to give us her perspectives on this study.
In this podcast, Dr. Casagrande gives us an inside look at this potential new therapy and talks about what’s involved in this exciting phase 3 of the study. If you are thinking about clinical trials and want to learn more, don’t miss my chat with Dr. Casagrande. To read more and download informational materials, click here.
Music Composed and Produced by, MusicWorksFoundry(TM) (ASCAP). All Rights Reserved.
© 2021, Pituitary World News. All rights reserved.